Richard Vincent | Chief Financial Officer |
Jim Breitmeyer | President & Chief Executive Officer |
Edwina Baskin-Bey | Acting Chief Medical Officer |
Carl Byrnes | Northland Securities |
Greetings, and welcome to Oncternal's Therapeutics Incorporated Fourth Quarter 2020 Financial Results Call. [Operator Instructions] As a reminder this conference is being recorded. It is now my pleasure to introduce your host Richard Vincent, Chief Financial Officer of Oncternal Therapeutics. Thank you sir.
You may begin.